Effectiveness of the Quotient® ADHD Assessment in a System of Care
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Attention Deficit and Disruptive Behavior Disorders
- Sponsor
- Kaiser Permanente
- Enrollment
- 207
- Locations
- 3
- Primary Endpoint
- Number of Participants With 25% Reduction in SNAP Scores
- Status
- Terminated
- Last Updated
- 8 years ago
Overview
Brief Summary
The study goal is to examine whether the use of an objective computerized neuroassessment (the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to improved outcomes among pediatric patients being assessed and treated for ADHD.
Detailed Description
This study is a randomized, controlled trial using a 2-phase data collection. The first phase is the initial assessment for ADHD and includes all patients eligible to be assessed for ADHD as determined by their clinician in the course of usual care. The baseline measurements will be used to compare groups at baseline, and also for longitudinal analyses of medication management. Patients are randomized at this point. Patients in both treatment arms who then receive an ADHD diagnosis and who start medication for ADHD will be eligible for the second phase of the study: three follow-up assessments over six months. Patients who do not have an ADHD diagnosis will not continue in the study, and will be treated by their clinician as usual.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients within the specified age range who are English speaking and who are presenting for ADHD assessment are eligible. An additional criterion is consent to be randomized.
Exclusion Criteria
- •Non English speaking
- •Refusal to participate
Outcomes
Primary Outcomes
Number of Participants With 25% Reduction in SNAP Scores
Time Frame: One month, 3 month and six month follow ups
Outcome measure reported is the number of participants with at least one 25% reduction in SNAP between visits. In treatment of ADHD, the therapeutic dose is defined as a 25% reduction in SNAP IV score between consecutive clinic visits. SNAP is itemized rating scale (Swanson, Nolan, and Pelham-IV Questionnaire) designed to measure ADHD symptoms and severity on a 4 point scale. It is based on DSM IV criteria, and is designed to measure attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) symptoms in children and young adults ages 6-18.
Secondary Outcomes
- Satisfaction With Care(Six months)
- Other Health Services Use(Baseline to six months)
- ADHD Symptomatology(6 months post baseline)
- Academic Performance(Baseline and Six Months)
- Persistence in Care(Baseline to Six Months)
- Medication Adherence(Baseline to six months)